Thrombolytic therapy in anticoagulated patients: Case series from rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF)

Sean Chen, Anne Hellkamp, Richard Becker, Scott Berkowitz, Guenter Breithardt, Keith Fox, Werner Hacke, Jonathan Halperin, Graeme Hankey, Kenneth Mahaffey, Christopher Nessel, Jonathan Piccini, Daniel Singer, Manesh Patel

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)446-446
Number of pages1
JournalJournal of the American College of Cardiology
Volume69
Issue number11
Publication statusPublished - 21 Mar 2017
Event66th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC) - Washington
Duration: 17 Mar 201719 Mar 2017

Cite this

Chen, S., Hellkamp, A., Becker, R., Berkowitz, S., Breithardt, G., Fox, K., Hacke, W., Halperin, J., Hankey, G., Mahaffey, K., Nessel, C., Piccini, J., Singer, D., & Patel, M. (2017). Thrombolytic therapy in anticoagulated patients: Case series from rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF). Journal of the American College of Cardiology, 69(11), 446-446.